Taipei Exchange - Delayed Quote TWD
Pharmosa Biopharm Inc. (6875.TWO)
51.60
+4.30
+(9.09%)
At close: 1:30:39 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
167,568
167,568
314,500
--
--
Cost of Revenue
40,665
40,665
--
--
--
Gross Profit
126,903
126,903
314,500
--
--
Operating Expense
345,470
345,470
317,324
271,533
259,120
Operating Income
-218,567
-218,567
-2,824
-271,533
-259,120
Net Non Operating Interest Income Expense
29,655
29,655
6,668
-149
-1,114
Pretax Income
-166,653
-166,653
8,456
-266,506
-256,479
Net Income Common Stockholders
-166,653
-166,653
8,456
-266,506
-256,479
Diluted NI Available to Com Stockholders
-166,653
-166,653
8,456
-266,506
-256,479
Basic EPS
-1.32
--
0.07
-2.70
-2.95
Diluted EPS
-1.32
--
0.07
-2.70
-2.95
Basic Average Shares
126,252.27
--
120,800
100,741
87,136.67
Diluted Average Shares
126,252.27
--
120,800
100,741
87,136.67
Total Expenses
386,135
386,135
317,324
271,533
259,120
Net Income from Continuing & Discontinued Operation
-166,653
-166,653
8,456
-266,506
-256,479
Normalized Income
-166,653
-166,653
8,456
-266,506
-256,479
Interest Income
32,074
32,074
9,525
500
100
Interest Expense
2,419
2,419
2,857
649
1,214
Net Interest Income
29,655
29,655
6,668
-149
-1,114
EBIT
-164,234
-164,234
11,313
-265,857
-255,265
EBITDA
-138,429
-138,429
34,634
-253,157
-243,465
Reconciled Cost of Revenue
40,665
40,665
--
--
--
Reconciled Depreciation
25,805
25,805
23,321
12,700
11,800
Net Income from Continuing Operation Net Minority Interest
-166,653
-166,653
8,456
-266,506
-256,479
Normalized EBITDA
-138,429
-138,429
34,634
-253,157
-243,465
12/31/2021 - 2/22/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6872.TWO NaviFUS Corp.
23.85
+0.63%
4911.TWO G&E Herbal Biotechnology Co., Ltd.
53.00
+0.76%
6838.TW Formosa Pharmaceuticals, Inc.
23.80
+1.71%
8279.TWO Syngen Biotech Co.,Ltd.
123.00
0.00%
6541.TW Tanvex BioPharma, Inc.
61.00
+2.35%
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
84.10
+1.45%
6492.TWO Senhwa Biosciences, Inc.
32.25
+1.10%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
89.40
+0.90%
4168.TWO GlycoNex Incorporation
16.45
+2.17%
6657.TW Energenesis Biomedical CO.,LTD.
58.80
+1.73%